Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare the abductor muscle strength measured with a dynamometer in patients with reverse oblique inter- or subtrochanteric fractures treated either with a proximal femur locking plate or a trochanteric nail.
"Proximal femur locking plates" stands for both the PF-LCP (Synthes) and the PeriLoc (Smith & Nephew). Trochanteric nails allowed in this study are the Proximal Femoral Nail Antirotation (PFNA), the Titanium Trochanteric Fixation Nail (TFN) and the Gamma Nail (GN).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Proximal femur locking plate | Active Comparator | Treatment of reverse oblique intertrochanteric or subtrochanteric fractures with a Proximal Femur Locking Compression Plate (PF-LCP, PF-LCP Hook Plate, PeriLoc) |
|
| Trochanteric nail | Other | Treatment of reverse oblique intertrochanteric or subtrochanteric fractures with Trochanteric Nails (PFNA, TFN, GN) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Proximal femur locking plate | Device | Proximal femur locking plate (PF-LCP, PF-LCP Hook Plate, Periloc) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Compare the functional outcome and abductor muscle strength measured with Lafayette Manual Muscle Tester in patients with reverse oblique inter- or subtrochanteric fractures treated either with a proximal femur locking plate or a trochanteric nail. | As hip abductors are the most important muscles around the hip joint, the primary outcome parameter will involve objectively measuring hip abductor strength. Muscle strength will be assessed with a portable handheld dynamometer (Model 01163, Lafayette Instrument Company, Lafayette, IN, USA). | one year |
| Measure | Description | Time Frame |
|---|---|---|
| Patient outcome | Patient outcome will be measured using the following outcome measurements: Mobility measured with the "timed up & go"-test (TUG), Lower Extremity Measure (LEM) for functional outcome, Length of hospital stay, Walking ability (Parker Mobility Score), Capacity to return to pre-residential status, Quality of life (Short Form-36 [SF-36]), Mortality. | one year |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Beate P. Hanson, MD | AO Clinical Investigation and Documentation, Davos, Switzerland | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Princess Alexandra Hospital | Woolloongabba | Queensland | 4102 | Australia | ||
| Cantonal Hospital Chur |
Not provided
Not provided
Not provided
Not provided
Not provided
| Intertrochanteric nail | Device | Intertrochanteric nail (PFNA, TFN, GN) |
|
|
| Pain scores on the Visual Analog Scale | Pain will be measured with the Visual Analogue Scale (VAS) (additionally assessed in a subgroup with the Brief Pain Inventory [BPI]). | one year |
| Patient satisfaction with the Visual Analogue Scale | Satisfaction measured with the VAS | one year |
| Abductor muscle function with the Trendelenburg sign analysis | Abductor muscle function test | one year |
| Surgical details | Skin-to-skin time, Fluoroscopy time, Blood loss, Blood transfusions, Surgeons experience. | Initial hospitalization |
| Local complications | Local complication will be recorded and categorized: Implant / surgery complications, Bone / fracture complications, Soft tissue / wound complications. | one year |
| Revision rate | Surgical revision includes all secondary surgical interventions that are related to the injury itself or the primary intervention. It is distinguished from planned revisions due to the injury (eg, planned soft tissue procedure) and revisions due to a complication. Revisions due to a complication are undertaken to resolve the problem and will therefore be documented in the complication form. | one year |
| Systemic or general complications | All complications affecting other regions of the body will be documented and evaluated as general/systemic complications, eg, thromboembolic complications, sepsis and others. | one year |
| Exploration of prognostic factors for the occurrence of complications, using the Fracture Risk Assessment Tool (FRAX) | Fracture risk prior to injury will be calculated with the Fracture Risk Assessment Tool [FRAX] (http://www.shef.ac.uk/FRAX/index.htm). Additionally, the fracture risk will be considered as a prognostic factor (in the absence of regular BMD measurements) for the analysis of complications. | Initial hospitalization |
| Quality of reduction | The results of fracture reduction are assessed with the following clinical and radiological evaluations : Varus/valgus deformity, Endo-/exorotation deformity, Limb length. | one year |
| Chur |
| 7000 |
| Switzerland |
| Cantonal Hospital Lucerne | Lucerne | 6000 | Switzerland |